文献速递心血管骨肌技术与安全CT

冠状动脉钙化扫描中基于机会性人工智能的骨密度测量验证

Validation of Opportunistic Artificial Intelligence-Based Bone Mineral Density Measurements in Coronary Artery Calcium Scans.
PubMed 文献 · J Am Coll Radiol · 2023-06-17

本研究验证了基于人工智能的自动骨密度测量工具AutoBMD,该工具已获FDA批准作为冠状动脉钙化扫描的机会性附加检查。在5,785例多民族动脉粥样硬化研究病例中,AutoBMD与手动测量强相关(R=0.85),检测骨质疏松的准确度达99.6%,且每份报告平均耗时15秒,远快于手动测量的5.5分钟。

要点

  • AutoBMD与手动骨密度测量强相关(R=0.85),检测骨质疏松准确度99.6%、敏感度96.7%、特异度97.7%。
  • AutoBMD每份报告平均耗时15秒,手动测量为5.5分钟,差异有统计学意义(P < .0001)。
  • AutoBMD报告骨密度并给出Z值和T值,可机会性检测骨质疏松和骨量减少,无需额外扫描或辐射。

核心结论

  • AutoBMD是FDA批准的人工智能机会性工具,可在冠状动脉钙化扫描中报告骨密度并提供Z值和T值,准确检测骨质疏松和骨量减少,结果与手动测量相当;无额外扫描成本和辐射,加之无症状骨质疏松高患病率,使其成为改善患者照护的有前景的候选工具。

研究设计与样本

  • 验证研究:深度学习模型使用132例冠状动脉钙化扫描(共7,649层)训练,以多民族动脉粥样硬化研究中先前报道的5,785例手动骨密度测量作为验证参考。

诊断标准与关键数值

  • AutoBMD与手动骨密度测量的均值±标准差分别为166.1 ± 47.9 mg/cc和163.1 ± 46 mg/cc(P = .006),两者强相关(R = 0.85,P < .0001);AutoBMD检测骨质疏松的准确度99.6%、敏感度96.7%、特异度97.7%、阳性预测值99.7%、阴性预测值99.8%。

临床应用与阅片要点

  • AutoBMD可机会性用于冠状动脉钙化扫描的骨密度报告,自动提供Z值和T值并检测骨质疏松和骨量减少;每份报告平均耗时15秒,手动测量为5.5分钟(P < .0001)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Previously we reported a manual method of measuring thoracic vertebral bone mineral density (BMD) using quantitative CT in noncontrast cardiac CT scans used for coronary artery calcium (CAC) scoring. In this report, we present validation studies of an artificial intelligence-based automated BMD measurement (AutoBMD) that recently received FDA approval as an opportunistic add-on to CAC scans.

METHODS: A deep learning model was trained to detect vertebral bodies. Subsequently, signal processing techniques were developed to detect intervertebral discs and the trabecular components of the vertebral body. The model was trained using 132 CAC scans comprising 7,649 slices. To validate AutoBMD, we used 5,785 cases of manual BMD measurements previously reported from CAC scans in the Multi-Ethnic Study of Atherosclerosis.

RESULTS: Mean ± SD for AutoBMD and manual BMD were 166.1 ± 47.9 mg/cc and 163.1 ± 46 mg/cc, respectively (P = .006). Multi-Ethnic Study of Atherosclerosis cases were 47.5% male and 52.5% female, with age 62.2 ± 10.3. A strong correlation was found between AutoBMD and manual measurements (R = 0.85, P < .0001). Accuracy, sensitivity, specificity, positive predictive value and negative predictive value for AutoBMD-based detection of osteoporosis were 99.6%, 96.7%, 97.7%, 99.7% and 99.8%, respectively. AutoBMD averaged 15 seconds per report versus 5.5 min for manual measurements (P < .0001).

CONCLUSIONS: AutoBMD is an FDA-approved, artificial intelligence-enabled opportunistic tool that reports BMD with Z-scores and T-scores and accurately detects osteoporosis and osteopenia in CAC scans, demonstrating results comparable to manual measurements. No extra cost of scanning and no extra radiation to patients, plus the high prevalence of asymptomatic osteoporosis, make AutoBMD a promising candidate to enhance patient care.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Naghavi, Atlas, Jaberzadeh, et al. Validation of Opportunistic Artificial Intelligence-Based Bone Mineral Density Measurements in Coronary Artery Calcium Scans. J Am Coll Radiol. 2023. PMID: 37336431. doi:10.1016/j.jacr.2023.05.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。